InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,708.98
(
1.61%
)
US TECH 100
19,395.20
(
2.85%
)
Dow Jones
41,920.13
(
1.00%
)
Brent Oil
73.81
(
1.97%
)
Bitcoin
63,085.50
(
2.29%
)
Post# of 253155
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

read_this_n0w

Send PM Follow Ignore
Followers 250
Posts 14020
Boards Moderated 3
Alias Born 07/07/2006

read_this_n0w

Re: read_this_n0w post# 90623

Tuesday, 02/16/2010 1:56:09 PM

Tuesday, February 16, 2010 1:56:09 PM

Post# of 253155
ALS results REMOVED from ALSWORLDWIDE



NEWSFLASH
INTERIM REPORT OF IPLEX FOR ALS

The Interim Report of the Investigational New Drug trial on the use of Iplex (mecasermin rinfabate) by middle-to-late stage Amyotrophic Lateral Sclerosis patients has been filed with the FDA, Insmed and Alpha Institutional Review Board. This report will be reprinted on this website once the requisite minimum thirty day waiting period is completed. Thank you for your patience.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up